十味香鹿膠囊治療乳腺增生。ǜ斡艏嫣的C)的臨床觀察
[Abstract]:Objective: to evaluate the efficacy and safety of Shiwei Xianglu capsule in the treatment of hyperplasia of mammary gland (liver depression and phlegm coagulation syndrome) by observing the changes of breast pain, breast mass and TCM syndromes before and after treatment. Methods: from July 2016 to March 2017, 48 patients with liver depression and phlegm coagulation were enrolled in the outpatient department of the first affiliated Hospital of Heilongjiang University of traditional Chinese Medicine. They were randomly divided into treatment group (Shiwei Xianglu capsule group) and control group (Rukang tablet group). In the treatment group, five tablets of Shiwei Xianglu capsule were given three times a day for two menstrual cycles. The control group was given three tablets of Rukang tablets every 3 times a day for two menstrual cycles. Observe the change of observation indexes after two menstrual cycles. The result is 1: 1. The total effective rate was 91.70 in the treatment group (Shiwei Xianglu capsule group) and 87.50 in the control group (Rukang tablet group). There was no significant difference in the effective rate between the treatment group (Shiwei Xianglu capsule group) and the control group (Rukang tablet group). TCM syndromes score: the two groups before and after treatment of TCM syndromes scores were significantly different (P0.05), after treatment there was no difference between the two groups (P0.05). Breast mass length: two groups before and after treatment there was a difference (P0.05), two groups of breast masses after treatment there was no significant difference (P0.05). 4. Days of breast pain: there was significant difference between the two groups before and after treatment (P0.05), but there was no significant difference between the two groups after treatment (P0.05) .5. Breast pain score: there was no significant difference between the two groups before and after treatment, there were differences before and after treatment (P0.05). The treatment group (Shiwei Xianglu capsule group) was superior to the control group (Rukang tablet group) .6. Safety index: there was no significant change before and after treatment. Conclusion: Shiwei Xianglu capsule has good effect in treating liver depression and phlegm coagulation type hyperplasia of mammary gland. Shiwei Xianglu capsule can obviously relieve breast pain (curative effect is better than Rukang tablet), shorten the time of breast pain, reduce breast mass, can obviously improve the TCM syndrome of patients, and have no obvious side effects.
【學(xué)位授予單位】:黑龍江中醫(yī)藥大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2017
【分類號】:R269
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 由鳳雙;劉春濤;閆春玲;趙廣才;張舒;;中藥外敷結(jié)合磁療治療乳腺增生病的臨床觀察[J];中外醫(yī)療;2017年01期
2 耿鳳勇;黎輝;鄭穎慧;馬小寧;張洪利;;三苯氧胺治療乳腺增生42例臨床分析[J];當(dāng)代醫(yī)學(xué);2016年36期
3 陳健;雷瑞美;葉曉青;;鉬靶Ⅹ線檢查在乳腺增生病中醫(yī)辨證分型中的應(yīng)用價(jià)值[J];新中醫(yī);2016年09期
4 劉丹;張蕾;張彥飛;于野;李智萌;貢濟(jì)宇;蔡廣知;;竹節(jié)香附素A的體外抗腫瘤活性研究[J];中藥藥理與臨床;2014年02期
5 胡克菲;郭琪;裴曉華;杜玉開;;435例女性乳腺增生癥影響因素的臨床研究[J];中國實(shí)驗(yàn)方劑學(xué)雜志;2013年09期
6 劉琴;李莉;陳光亮;;乳腺增生病的辨證論治研究概況[J];安徽醫(yī)藥;2012年12期
7 鄧遠(yuǎn)輝;劉瑜彬;羅淑文;黎雄;鄧金寶;;α-香附酮的分離及其解熱鎮(zhèn)痛作用研究[J];中藥新藥與臨床藥理;2012年06期
8 劉曉菲;;宋愛莉教授治療乳腺增生病經(jīng)驗(yàn)總結(jié)[J];中國中醫(yī)藥現(xiàn)代遠(yuǎn)程教育;2010年18期
9 王政澤;張衛(wèi)華;李青;;乳腺增生病中醫(yī)證型之主證研究[J];實(shí)用中醫(yī)藥雜志;2010年09期
10 曲宏民;曲萬利;匡麗;師麗娟;;太乙痛痹貼治療乳腺增生42例[J];中醫(yī)外治雜志;2009年06期
,本文編號:2228352
本文鏈接:http://sikaile.net/zhongyixuelunwen/2228352.html